Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice

Francesca Ferrera, Daniela Fenoglio, Maurizio Cutolo, Giuseppe Balbi, Alessia Parodi, Florinda Battaglia, Francesca Kalli, Domenico Barone, Francesco Indiveri, Domenico Criscuolo, Gilberto Filaci

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A previous study showed that a tolerogenic gene vaccine based on a IgG1Fc-pCons chimera (here named GX101) protects NZB/NZW mice from SLE development. The present study was aimed at identifying the most effective schedule of immunization and the possible involvement of CD4+ Foxp3+ Treg in the mechanism of action, in view of its eventual translation to the human studies. NZB/NZW mice were vaccinated with B lymphocytes made transgenic by spontaneous transgenesis with a gene coding for a chimeric IgG1Fc-pCons construct. Different schedules of vaccination were set in relation to the timing and number of administrations. Survival, proteinuria levels, and CD4+ Foxp3+ Treg frequency were monitored during the full experiments. GX101-treated mice showed delayed disease onset and delayed mortality than controls. GX101 effects were implemented by early as well as repeated vaccine administrations. GX101 vaccination was associated with increased frequencies of CD4+ CD25+ Foxp3+ Treg with respect to controls. This study demonstrates that early and repeated immunizations with GX101 vaccine provide a better outcome than late or single vaccine administration regarding onset/development in SLE-prone mice, acting as a possible disease-modifying approach. Vaccine effects are likely related to CD4+ Foxp3+ Treg cell expansion.

Original languageEnglish
Pages (from-to)255-260
Number of pages6
JournalClinical and Experimental Medicine
Volume15
Issue number3
DOIs
Publication statusPublished - Jul 25 2014

Fingerprint

Vaccination
Vaccines
Inbred NZB Mouse
Immunization
Genes
Immunization Schedule
Gene Transfer Techniques
Lymphocytes
Regulatory T-Lymphocytes
Proteinuria
Appointments and Schedules
B-Lymphocytes
Survival
Mortality
Experiments

Keywords

  • DMARD
  • DNA vaccination
  • Immune tolerance
  • SLE
  • Treg

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice. / Ferrera, Francesca; Fenoglio, Daniela; Cutolo, Maurizio; Balbi, Giuseppe; Parodi, Alessia; Battaglia, Florinda; Kalli, Francesca; Barone, Domenico; Indiveri, Francesco; Criscuolo, Domenico; Filaci, Gilberto.

In: Clinical and Experimental Medicine, Vol. 15, No. 3, 25.07.2014, p. 255-260.

Research output: Contribution to journalArticle

Ferrera, F, Fenoglio, D, Cutolo, M, Balbi, G, Parodi, A, Battaglia, F, Kalli, F, Barone, D, Indiveri, F, Criscuolo, D & Filaci, G 2014, 'Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice', Clinical and Experimental Medicine, vol. 15, no. 3, pp. 255-260. https://doi.org/10.1007/s10238-014-0303-8
Ferrera, Francesca ; Fenoglio, Daniela ; Cutolo, Maurizio ; Balbi, Giuseppe ; Parodi, Alessia ; Battaglia, Florinda ; Kalli, Francesca ; Barone, Domenico ; Indiveri, Francesco ; Criscuolo, Domenico ; Filaci, Gilberto. / Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice. In: Clinical and Experimental Medicine. 2014 ; Vol. 15, No. 3. pp. 255-260.
@article{cb87f9f316de4b8a8bf662245541a2b5,
title = "Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice",
abstract = "A previous study showed that a tolerogenic gene vaccine based on a IgG1Fc-pCons chimera (here named GX101) protects NZB/NZW mice from SLE development. The present study was aimed at identifying the most effective schedule of immunization and the possible involvement of CD4+ Foxp3+ Treg in the mechanism of action, in view of its eventual translation to the human studies. NZB/NZW mice were vaccinated with B lymphocytes made transgenic by spontaneous transgenesis with a gene coding for a chimeric IgG1Fc-pCons construct. Different schedules of vaccination were set in relation to the timing and number of administrations. Survival, proteinuria levels, and CD4+ Foxp3+ Treg frequency were monitored during the full experiments. GX101-treated mice showed delayed disease onset and delayed mortality than controls. GX101 effects were implemented by early as well as repeated vaccine administrations. GX101 vaccination was associated with increased frequencies of CD4+ CD25+ Foxp3+ Treg with respect to controls. This study demonstrates that early and repeated immunizations with GX101 vaccine provide a better outcome than late or single vaccine administration regarding onset/development in SLE-prone mice, acting as a possible disease-modifying approach. Vaccine effects are likely related to CD4+ Foxp3+ Treg cell expansion.",
keywords = "DMARD, DNA vaccination, Immune tolerance, SLE, Treg",
author = "Francesca Ferrera and Daniela Fenoglio and Maurizio Cutolo and Giuseppe Balbi and Alessia Parodi and Florinda Battaglia and Francesca Kalli and Domenico Barone and Francesco Indiveri and Domenico Criscuolo and Gilberto Filaci",
year = "2014",
month = "7",
day = "25",
doi = "10.1007/s10238-014-0303-8",
language = "English",
volume = "15",
pages = "255--260",
journal = "Zeitschrift für Die Gesamte Experimentelle Medizin",
issn = "1591-8890",
publisher = "Springer-Verlag Italia",
number = "3",

}

TY - JOUR

T1 - Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice

AU - Ferrera, Francesca

AU - Fenoglio, Daniela

AU - Cutolo, Maurizio

AU - Balbi, Giuseppe

AU - Parodi, Alessia

AU - Battaglia, Florinda

AU - Kalli, Francesca

AU - Barone, Domenico

AU - Indiveri, Francesco

AU - Criscuolo, Domenico

AU - Filaci, Gilberto

PY - 2014/7/25

Y1 - 2014/7/25

N2 - A previous study showed that a tolerogenic gene vaccine based on a IgG1Fc-pCons chimera (here named GX101) protects NZB/NZW mice from SLE development. The present study was aimed at identifying the most effective schedule of immunization and the possible involvement of CD4+ Foxp3+ Treg in the mechanism of action, in view of its eventual translation to the human studies. NZB/NZW mice were vaccinated with B lymphocytes made transgenic by spontaneous transgenesis with a gene coding for a chimeric IgG1Fc-pCons construct. Different schedules of vaccination were set in relation to the timing and number of administrations. Survival, proteinuria levels, and CD4+ Foxp3+ Treg frequency were monitored during the full experiments. GX101-treated mice showed delayed disease onset and delayed mortality than controls. GX101 effects were implemented by early as well as repeated vaccine administrations. GX101 vaccination was associated with increased frequencies of CD4+ CD25+ Foxp3+ Treg with respect to controls. This study demonstrates that early and repeated immunizations with GX101 vaccine provide a better outcome than late or single vaccine administration regarding onset/development in SLE-prone mice, acting as a possible disease-modifying approach. Vaccine effects are likely related to CD4+ Foxp3+ Treg cell expansion.

AB - A previous study showed that a tolerogenic gene vaccine based on a IgG1Fc-pCons chimera (here named GX101) protects NZB/NZW mice from SLE development. The present study was aimed at identifying the most effective schedule of immunization and the possible involvement of CD4+ Foxp3+ Treg in the mechanism of action, in view of its eventual translation to the human studies. NZB/NZW mice were vaccinated with B lymphocytes made transgenic by spontaneous transgenesis with a gene coding for a chimeric IgG1Fc-pCons construct. Different schedules of vaccination were set in relation to the timing and number of administrations. Survival, proteinuria levels, and CD4+ Foxp3+ Treg frequency were monitored during the full experiments. GX101-treated mice showed delayed disease onset and delayed mortality than controls. GX101 effects were implemented by early as well as repeated vaccine administrations. GX101 vaccination was associated with increased frequencies of CD4+ CD25+ Foxp3+ Treg with respect to controls. This study demonstrates that early and repeated immunizations with GX101 vaccine provide a better outcome than late or single vaccine administration regarding onset/development in SLE-prone mice, acting as a possible disease-modifying approach. Vaccine effects are likely related to CD4+ Foxp3+ Treg cell expansion.

KW - DMARD

KW - DNA vaccination

KW - Immune tolerance

KW - SLE

KW - Treg

UR - http://www.scopus.com/inward/record.url?scp=84938422707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938422707&partnerID=8YFLogxK

U2 - 10.1007/s10238-014-0303-8

DO - 10.1007/s10238-014-0303-8

M3 - Article

VL - 15

SP - 255

EP - 260

JO - Zeitschrift für Die Gesamte Experimentelle Medizin

JF - Zeitschrift für Die Gesamte Experimentelle Medizin

SN - 1591-8890

IS - 3

ER -